Hyundai and Kia announced on May 22 that they signed an agreement with Incheon International Airport Corporation in South Korea and will begin a demonstration of the Electric Vehicle Automatic ...

What just happened? Apple's Eddy Cue testified in court yesterday in the remedies phase of the DoJ's lawsuit against Google parent Alphabet, and he had a lot to say. Cupertino's SVP of services ...

Footage reportedly shot at an undisclosed Chinese factory appears to show a robot violently "lashing out" at workers in a clip that's since gone viral. The security camera video shows a robot ...

Microsoft’s Bing or DuckDuckGo probably won’t disrupt Google’s dominance in search, said Apple senior vice president of services Eddy Cue — but AI services easily could. Cue was returning ...

AI technology is advancing so rapidly that the iPhone could be outdated in the next decade, Apple services chief Eddy Cue said today when testifying in the Google vs. DoJ antitrust case (via ...

Eddy Cue, Apple's (NASDAQ:AAPL) senior vice president of services, said on Tuesday that the company is exploring the option of adding artificial intelligence search options to its Safari web browser.

Alphabet and Apple shares sank Wednesday after Eddy Cue, Apple's services chief, said he believes that AI search engines will eventually replace standard search engines such as Google, according ...

Ronnie O’Sullivan is still making changes to his equipment (Picture: Getty Images) Ronnie O’Sullivan has continued to make changes to his cue, even in the middle of his World Snooker ...

Cue Clothing and its sister brand Veronika Maine have poached a new chief executive from rival womenswear label Trenery in the first big move by the business since it was sold to British investor ...

"One of the annoying things about working with robots is collecting so much data on the robot doing different tasks," said Kushal Kedia, a doctoral student in the field of computer science.

But while its peers have largely focused on CAR-Ts and bispecifics, the German drugmaker has paid Cue Biopharma $12 million for a novel preclinical program that could eliminate some of the risks ...

Cue Biopharma’s preclinical candidate molecule binds to a B cell specific membrane protein and in parallel selectively engages virus-specific memory killer T cells. This enables it to ...